Orion Pharma

Orion Corporation is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion Corporation has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion Corporation are used to treat cancer, neurological diseases and respiratory diseases, among others. In 2024 Orion Group's net sales amounted to EUR 1,542 million and the company employed about 3,700 professionals worldwide, dedicated to building well-being. Orion Group's A and B shares are listed on Nasdaq Helsinki. Product related questions and feedback: Beware of any recruitment scam using Orion Pharma’s name Be cautious of recruitment scams where individuals pose as Orion Pharma employees or authorized recruiters. Orion Pharma will never request payment, personal financial information, or any favours at any stage of our hiring process.